Tsuchikama lab develops promising treatment for brain tumors
Recent research from the lab of Kyoji Tsuchikama, PhD, associate professor in the Texas Therapeutics Institute at the Brown Foundation Institute for Molecular Medicine, showing the ability of their antibody-drug conjugate (ADC) to deliver anti-tumor payloads to brain tumors has…
Research on antibody-drug conjugates shows promise in fighting breast cancer
Research from the lab of Kyoji Tsuchikama, PhD, assistant professor in the Texas Therapeutics Institute at The Brown Foundation Institute of Molecular Medicine, on a new potential treatment for combating breast cancer has been published in the June edition of…
Pages